ADVFN - Advanced Financial Network.
HOME» NYSE » B » BCR Stock Price » BCR Stock News

Bard C R Share News

 Bard (c.r.), Inc. Stock Price
BCR Stock Price
 Bard (c.r.), Inc. Stock Chart
BCR Stock Chart
 Bard (c.r.), Inc. Stock News
BCR Stock News
 Bard (c.r.), Inc. Company Information
BCR Company Information
 Bard (c.r.), Inc. Stock Trades
BCR Stock Trades

C.R. Bard 3Q Net Down 1.5% On Charges; Sales Fall Short

DOW JONES NEWSWIRES C.R. Bard Inc.'s (BCR) third-quarter profit fell 1.5% on acquisition and other charges as the medical-products maker reported revenue below analysts' expectations. The company--which makes vascular, urology and oncology devices--had seen profit and sales rebound in recent quarters as health-care spending has rebounded somewhat, although Americans have been cutting back on medical care lately. C.R. Bard posted earnings of $127.5 million, or $1.34 a share, compared with $129.5 million, or $1.31 a share, a year earlier. Shares outstanding fell 4% and the latest quarter included 9 cents of charges. Revenue rose 6.5% to $678.4 million and climbed 8% excluding currency fluctuations. Analysts, on average, expected earnings of $1.40 on revenue of $686.74 million. The company in July gave a mixed third-quarter forecast: earnings of $1.37 to $1.41 on revenue of $688 million to $701 million. Gross margin rose to a record 62.9% from 62.2%, but that was more than offset by overhead costs climbing 13%. The vascular business was Bard's biggest by revenue, and it climbed 13% on a constant currency basis. Similarly sized urology and vascular had lower growth. Shares of C.R. Bard closed Thursday at $85.14 and were inactive after-hours. -By Yogita Patel and Kevin Kingsbury, Dow Jones Newswires; 212-416-2262; yogita.patel@dowjones.com

Stock News for Bard C R (BCR)
DateTimeHeadline
06/25/201507:30:00 The New England Journal of Medicine publishes LEVANT 2 results...
06/18/201513:37:45Current Report Filing (8-k)
06/16/201515:57:35Annual Report of Employee Stock Plans (11-k)
06/10/201516:06:00Bard Announces $500 Million Share Repurchase Authorization
06/10/201516:05:00Bard Increases Quarterly Dividend
06/09/201511:50:00CMS Further Improves Reimbursement for Lutonix DCB for Outpatient...
05/28/201516:27:35Specialized Disclosure Report (sd)
05/26/201510:45:00Bard to Present at Jefferies Healthcare Conference
05/20/201512:15:10What Is the S&P 500 Index?
05/06/201506:04:28Current Report Filing (8-k)
05/05/201510:30:00Bard to Present at the Bank of America Merrill Lynch Healthcare...
04/29/201517:37:36Statement of Changes in Beneficial Ownership (4)
04/29/201517:37:36Statement of Changes in Beneficial Ownership (4)
04/26/201503:00:38C.R. Bard Stock Rating Reaffirmed by Brean Capital (BCR)
04/24/201513:46:57Quarterly Report (10-q)
04/24/201510:52:50Barclays Boosts C.R. Bard Price Target to $185.00 (BCR)
04/24/201507:43:59C.R. Bard Upgraded at Bank of America (BCR)
04/23/201516:20:52Current Report Filing (8-k)
04/23/201516:05:00Bard Announces First Quarter Results
04/17/201506:03:35Current Report Filing (8-k)

Bard C R and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad